Parkinson’s Disease is a chronic and progressive disease of the nervous system and it became worse over time. It is the second most common neurological disorder. In ordinary Conditions, nerve cells exhibit in cerebrum and delivers a neurotransmitter called dopamine that oversees a development, feelings, and co-appointment yet because of unhealthy individual dopamine creation, hence the individual end up with control the development ordinarily. In Germany, has a lifetime prevalence of between 0.1 and 0.3% of the population.
Related: Parkinson’s Conference | Parkinson’s Disease Conference | Parkinson’s Congress | Movement Disorder Conferences | Neuroscience Conferences | Neurology Conferences
Related Conferences:
World Congress on Parkinson’s and Movement Disorders, July 23-24, 2019 at Berlin, Germany | 5th Global Experts Meeting on Parkinson’s, Huntington’s & Movement Disorders, May 08-09, 2019, at Tokyo, Japan | 5th World Parkinson Congress, June 4-7,2019, at Kyoto, Japan | 5th International Conference on Parkinson’s disease and Movement Disorders, October 19-20, 2018, at New York, USA | Movement Disorders in Children and Young Adults, November 22-23, 2018, at Groningen, Netherlands
Related Association and Societies:
American Academy of Neurology; Movement Disorders Society; The International Parkinson and Movement Disorder Society; Canadian Movement Disorders Group; UK Parkinson’s Action Network; European Neurological Society; European Parkinson’s Disease Association; Danish Movement Disorder Society; Italian Society for the study of Parkinson Disease; Extrapyramidal Diseases and Dementia; Movement Disorder Society of Australia; Parkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease Society; Movement Disorder Society of Japan
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
